KHATRI AMIT,MENSING SVEN,DUTTA SANDEEP,COHEN DANIEL E.,PODSADECKI THOMAS J.,BRUN SCOTT C.,AWNI WALID M.,DUMAS EMILY O.,KLEIN CHERI E.,BERNSTEIN BARRY M.,MENON RAJEEV M.
申请号：
NZ62553912
公开号：
NZ625539A
申请日:
2012.10.19
申请国别(地区):
NZ
年份:
2016
代理人:
摘要：
Provided are therapeutic regimens for the treatment of hepatitis C virus (HCV). The regimens comprise the administration of at least PSI-7977 (sofosbuvir) and a HCV NS5A inhibitor, such as GS-5885 (ledipasvir), wherein the regimens do not include administration of either interferon or ribavirin, and last for 6-12 weeks.
